Correspondence on ‘Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients’

By sjmartinez • September 21, 2023

Kermani TA. Correspondence on 'Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients'. Ann Rheum Dis. 2023 Oct;82(10):e214. doi: 10.1136/annrheumdis-2021-219879. Epub 2021 Jan 21. PMID: 33478954.

Tags: biological therapy, covid-19, Publications, Rheumatology, systemic vasculitis

Silicosis in the Artificial Stone Countertop Industry: An Official American Thoracic Society Workshop Report

Gandhi SA, Liu GY, Fazio JC, Amubieya O, Barnes H, Cavalin C, Cohen RA, Fireman E, Garcia SR, Harrison RJ, Houlroyd JL, Hua JT, Jones[...]

Development of a single item patient reported measure of treatment side effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement

Berthelsen DB, Horgan B, Simon L, Ioannidis JPA, Goel N, Tugwell P, Balay-Dustrude E, Bartlett SJ, Bingham CO, Boers M, Bouillot C, Böhm P, Choy[...]

Effect of incorporating 1 avocado per day on lipoprotein particle concentrations compared to habitual intake in adults with abdominal obesity: An ancillary study of the Habitual Diet and Avocado Trial, a randomized controlled trial

Damani JJ, Kris-Etherton PM, Matthan NR, Li Z, Sabaté J, Reboussin DM, Petersen KS. Effect of incorporating 1 avocado per day on lipoprotein particle concentrations[...]